- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 3 x ZN: ZINC ION(Non-covalent)
- 5 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PC1.2: 12 residues within 4Å:- Chain A: Y.497, Y.523, N.525
- Chain E: Y.112, R.119
- Chain I: M.21, N.24, Y.27, V.28
- Chain J: L.32
- Ligands: CDL.3, CDL.4
8 PLIP interactions:2 interactions with chain I, 3 interactions with chain A, 2 interactions with chain E, 1 interactions with chain J- Hydrogen bonds: I:N.24, A:N.525
- pi-Cation interactions: I:Y.27, A:Y.523, E:Y.112
- Salt bridges: A:D.498, E:R.119
- Hydrophobic interactions: J:L.32
PC1.19: 10 residues within 4Å:- Chain K: Y.497, D.498, Y.523, N.525
- Chain O: Y.112, R.119
- Chain S: Y.27, V.31
- Ligands: CDL.18, CDL.21
9 PLIP interactions:4 interactions with chain K, 3 interactions with chain O, 2 interactions with chain S- Hydrogen bonds: K:Y.523, K:N.525
- Salt bridges: K:D.498, O:R.119, O:R.119
- pi-Cation interactions: K:Y.523, O:Y.112, S:Y.27
- Hydrophobic interactions: S:V.31
PC1.30: 9 residues within 4Å:- Chain N: L.282, Y.286
- Chain O: F.110, V.114, G.118
- Chain Q: K.21, V.22, M.23, T.24
5 PLIP interactions:3 interactions with chain Q, 1 interactions with chain O, 1 interactions with chain N- Hydrogen bonds: Q:V.22, Q:M.23, Q:T.24
- Hydrophobic interactions: O:V.114, N:L.282
PC1.36: 11 residues within 4Å:- Chain 2: K.34, S.37, V.38, L.42
- Chain U: M.1, F.9
- Chain W: P.16, I.19, L.23
- Ligands: PC1.56, 3PE.58
4 PLIP interactions:2 interactions with chain W, 1 interactions with chain 2, 1 interactions with chain U- Hydrophobic interactions: W:I.19, W:L.23, 2:L.42, U:F.9
PC1.56: 14 residues within 4Å:- Chain 2: G.53, Y.57, S.60, H.61
- Chain 3: Y.84, F.88
- Chain U: W.106, P.110, L.112, L.113, L.120
- Chain W: S.22
- Ligands: PC1.36, 3PE.58
7 PLIP interactions:5 interactions with chain U, 2 interactions with chain 2- Hydrophobic interactions: U:W.106, U:P.110, U:L.112, U:L.113, U:L.113
- Hydrogen bonds: 2:S.60, 2:S.60
- 9 x CDL: CARDIOLIPIN(Non-covalent)
CDL.3: 16 residues within 4Å:- Chain A: Y.417, Q.421, R.520, R.521, W.524, N.525, R.526
- Chain C: S.9, L.10, L.11, I.24, F.227, Y.228
- Chain J: W.21
- Ligands: PC1.2, CDL.4
14 PLIP interactions:9 interactions with chain A, 4 interactions with chain C, 1 interactions with chain J- Hydrophobic interactions: A:N.525, C:I.24, C:Y.228, C:Y.228, J:W.21
- Hydrogen bonds: A:Y.523, A:N.525, A:R.526, C:S.9
- Salt bridges: A:R.520, A:R.521, A:R.521, A:R.526, A:R.526
CDL.4: 14 residues within 4Å:- Chain A: R.520, N.525
- Chain C: I.48, Y.228, Y.232, L.236, A.243
- Chain D: Y.287
- Chain E: R.119, Y.122, A.123, I.126
- Ligands: PC1.2, CDL.3
13 PLIP interactions:2 interactions with chain D, 5 interactions with chain E, 4 interactions with chain C, 2 interactions with chain A- Hydrogen bonds: D:Y.287, D:Y.287, E:R.119, C:Y.228, A:N.525
- Hydrophobic interactions: E:Y.122, E:A.123, E:I.126, C:I.48, C:Y.232, C:A.243
- Salt bridges: E:R.119, A:R.520
CDL.12: 15 residues within 4Å:- Chain C: S.33, Y.34, W.35, F.38, Y.109, A.241, F.242
- Chain F: H.76
- Chain G: K.37, E.40, N.41, W.42, A.45
- Ligands: 3PE.11, CDL.14
11 PLIP interactions:1 interactions with chain F, 6 interactions with chain G, 4 interactions with chain C- Salt bridges: F:H.76, G:K.37
- Hydrophobic interactions: G:N.41, G:W.42, G:A.45, C:W.35, C:W.35, C:A.241
- Hydrogen bonds: G:E.40, G:N.41, C:Y.34
CDL.14: 10 residues within 4Å:- Chain C: Y.34
- Chain D: L.281, L.282, A.285, R.288, R.289
- Chain G: L.26, L.30, K.37
- Ligands: CDL.12
6 PLIP interactions:3 interactions with chain D, 1 interactions with chain C, 2 interactions with chain G- Hydrophobic interactions: D:L.281
- Hydrogen bonds: D:R.289, C:Y.34
- Salt bridges: D:R.288, G:K.37, G:K.37
CDL.18: 15 residues within 4Å:- Chain K: Y.417, Q.421, R.520, R.521, W.524, N.525, R.526
- Chain M: S.9, L.11, I.24, Y.228, W.239
- Chain T: W.21
- Ligands: PC1.19, CDL.21
11 PLIP interactions:5 interactions with chain M, 5 interactions with chain K, 1 interactions with chain T- Hydrophobic interactions: M:L.11, M:Y.228, M:W.239, T:W.21
- Hydrogen bonds: M:S.9, M:S.9, K:N.525, K:R.526
- Salt bridges: K:R.520, K:R.521, K:R.526
CDL.21: 18 residues within 4Å:- Chain K: R.520, N.525
- Chain M: I.48, Y.228, Y.232, L.236, W.239, A.243, F.246, F.251
- Chain N: Y.287
- Chain O: R.119, Y.122, L.125, I.126, L.128
- Ligands: CDL.18, PC1.19
18 PLIP interactions:9 interactions with chain M, 2 interactions with chain K, 2 interactions with chain N, 5 interactions with chain O- Hydrophobic interactions: M:I.48, M:L.236, M:W.239, M:A.243, M:F.246, M:F.251, M:F.251, O:Y.122, O:L.125, O:I.126, O:L.128
- Hydrogen bonds: M:Y.228, M:Y.232, K:N.525, N:Y.287, N:Y.287
- Salt bridges: K:R.520, O:R.119
CDL.29: 12 residues within 4Å:- Chain M: Y.34, F.38, F.242
- Chain N: A.285, R.288, R.289
- Chain Q: L.26, L.30, K.33, I.34, K.37
- Ligands: CDL.31
9 PLIP interactions:1 interactions with chain P, 3 interactions with chain M, 3 interactions with chain Q, 2 interactions with chain N- Salt bridges: P:H.76, Q:K.33, Q:K.37, Q:K.37, N:R.288, N:R.289
- Hydrophobic interactions: M:Y.34, M:F.38, M:F.38
CDL.31: 11 residues within 4Å:- Chain M: S.33, Y.34, W.35, F.38
- Chain P: H.76
- Chain Q: K.37, V.38, N.41, A.45
- Ligands: 3PE.25, CDL.29
9 PLIP interactions:1 interactions with chain P, 4 interactions with chain M, 4 interactions with chain Q- Salt bridges: P:H.76, M:K.234, Q:K.37
- Hydrophobic interactions: M:W.35, M:F.38, Q:V.38, Q:N.41, Q:A.45
- Hydrogen bonds: M:Y.34
CDL.39: 14 residues within 4Å:- Chain 3: Y.55, M.60, K.66, M.67, A.70, V.71
- Chain U: R.6, W.7, L.8, L.19, I.22, F.403, V.474
- Ligands: 3PE.58
11 PLIP interactions:7 interactions with chain U, 4 interactions with chain 3- Hydrophobic interactions: U:L.8, U:L.19, U:I.22, U:I.22, U:F.403, U:V.474, 3:A.70, 3:V.71
- Hydrogen bonds: U:R.6, 3:Y.55
- Salt bridges: 3:K.66
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.5: 20 residues within 4Å:- Chain C: L.46, Q.49, I.50, G.53, V.54, L.56, Y.60, R.85, H.88, A.92, A.134, G.137, Y.138, L.140, P.141, H.189, Y.190, P.193, F.194, Y.280
15 PLIP interactions:15 interactions with chain C,- Hydrophobic interactions: C:L.46, C:Q.49, C:L.56, C:Y.60, C:L.140, C:L.140, C:Y.190, C:P.193, C:F.194
- Salt bridges: C:R.85, C:R.85
- pi-Stacking: C:H.88, C:H.189
- Metal complexes: C:H.88, C:H.189
HEM.6: 21 residues within 4Å:- Chain C: W.36, G.39, A.42, G.43, F.95, V.99, H.102, I.103, R.105, S.111, V.119, W.120, G.123, V.124, I.126, S.200, H.203, L.204, L.207, S.212, N.213
22 PLIP interactions:22 interactions with chain C,- Hydrophobic interactions: C:A.42, C:F.95, C:V.99, C:I.103, C:V.119, C:W.120, C:V.124, C:I.126, C:L.207
- Hydrogen bonds: C:W.36, C:G.39, C:S.111, C:S.212, C:S.212, C:N.213
- Salt bridges: C:H.102, C:R.105, C:R.105, C:R.116
- pi-Cation interactions: C:R.105
- Metal complexes: C:H.102, C:H.203
HEM.22: 22 residues within 4Å:- Chain M: Q.49, I.50, G.53, V.54, L.56, A.57, Y.60, V.71, R.85, H.88, A.89, A.92, F.95, A.134, G.137, Y.138, L.140, P.141, H.189, Y.190, P.193, Y.280
12 PLIP interactions:12 interactions with chain M,- Hydrophobic interactions: M:Q.49, M:L.56, M:Y.60, M:A.89, M:F.95, M:L.140, M:Y.190, M:P.193
- Salt bridges: M:R.85, M:R.85
- Metal complexes: M:H.88, M:H.189
HEM.23: 19 residues within 4Å:- Chain M: W.36, G.39, G.43, F.95, V.99, H.102, I.103, R.105, S.111, W.120, G.123, V.124, I.126, S.200, H.203, L.204, L.207, S.212, N.213
18 PLIP interactions:18 interactions with chain M,- Hydrophobic interactions: M:F.95, M:V.99, M:W.120, M:W.120, M:V.124, M:I.126, M:L.207
- Hydrogen bonds: M:W.36, M:W.36, M:G.39, M:S.111, M:N.213
- Salt bridges: M:H.102, M:R.105, M:R.105
- pi-Cation interactions: M:R.105
- Metal complexes: M:H.102, M:H.203
- 29 x 3PE: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
3PE.7: 10 residues within 4Å:- Chain C: P.14, I.15, S.17, T.18
- Chain M: F.118, G.198, L.202, A.205, Q.209
- Chain P: P.122
Ligand excluded by PLIP3PE.8: 9 residues within 4Å:- Chain C: F.118, L.202, A.205, A.206, Q.209
- Chain F: P.122
- Chain M: P.14, I.15, T.18
Ligand excluded by PLIP3PE.9: 15 residues within 4Å:- Chain C: F.324, R.325, P.326, I.327, Y.328, I.374, L.375, V.378, G.379, I.382
- Chain F: L.16, H.20, L.24, Y.35
- Ligands: 3PE.15
Ligand excluded by PLIP3PE.10: 10 residues within 4Å:- Chain C: Y.100, F.104, W.279, L.282, P.283, G.343, W.344, C.347, Q.348, F.365
Ligand excluded by PLIP3PE.11: 12 residues within 4Å:- Chain C: W.35, Y.108, Y.109, S.323, F.332, W.333
- Chain F: Y.31, Y.78
- Chain G: N.41, S.44, L.48
- Ligands: CDL.12
Ligand excluded by PLIP3PE.15: 11 residues within 4Å:- Chain C: P.326, I.327, I.331
- Chain F: L.16, Q.19, H.20, S.23, K.26, R.27
- Chain G: I.43
- Ligands: 3PE.9
Ligand excluded by PLIP3PE.16: 6 residues within 4Å:- Chain D: Y.286
- Chain E: F.110
- Chain G: K.21, V.22, M.23, T.24
Ligand excluded by PLIP3PE.20: 5 residues within 4Å:- Chain C: F.118
- Chain F: Q.118, R.119, I.121
- Chain M: R.7
Ligand excluded by PLIP3PE.24: 6 residues within 4Å:- Chain E: L.131, V.134, L.135
- Chain J: L.32
- Chain M: T.166, W.170
Ligand excluded by PLIP3PE.25: 13 residues within 4Å:- Chain M: W.35, Y.108, Y.109, S.323, Q.329, W.333, L.336
- Chain P: Y.31, Y.78
- Chain Q: N.41, L.48, L.49
- Ligands: CDL.31
Ligand excluded by PLIP3PE.26: 11 residues within 4Å:- Chain M: P.326, I.327, G.330, I.331, L.334
- Chain P: Q.19, H.20, S.23, K.26, R.27
- Chain Q: I.43
Ligand excluded by PLIP3PE.27: 5 residues within 4Å:- Chain M: Y.252
- Chain N: K.80, G.81, I.82, I.274
Ligand excluded by PLIP3PE.37: 9 residues within 4Å:- Chain U: F.172, T.180, M.181, H.182, L.192, L.200, V.284, F.287
- Ligands: 3PE.43
Ligand excluded by PLIP3PE.38: 11 residues within 4Å:- Chain U: H.236, F.240, W.290, L.299, D.300, T.303, Y.306
- Chain W: M.95, F.98, W.102
- Ligands: 3PE.51
Ligand excluded by PLIP3PE.40: 9 residues within 4Å:- Chain U: Y.336, L.341, V.344, F.348, Q.413, W.417
- Chain X: M.1, T.3
- Ligands: 3PE.47
Ligand excluded by PLIP3PE.41: 7 residues within 4Å:- Chain 3: V.71, F.72
- Chain U: L.411, C.469, V.472, T.475
- Chain X: I.16
Ligand excluded by PLIP3PE.42: 7 residues within 4Å:- Chain U: F.218
- Chain W: G.32, Y.35, M.36, S.47
- Chain Z: L.93
- Ligands: 3PE.49
Ligand excluded by PLIP3PE.43: 8 residues within 4Å:- Chain U: F.172, M.181, F.196
- Chain W: Y.84, L.88, V.94
- Ligands: 3PE.37, 3PE.52
Ligand excluded by PLIP3PE.45: 4 residues within 4Å:- Chain U: W.452, L.455
- Chain V: L.19
- Ligands: 3PE.55
Ligand excluded by PLIP3PE.46: 4 residues within 4Å:- Chain 1: V.17
- Chain U: A.327
- Chain V: V.53, I.78
Ligand excluded by PLIP3PE.47: 9 residues within 4Å:- Chain Q: K.28, P.31
- Chain U: Y.336
- Chain V: L.51, S.55, L.58, R.62, S.63
- Ligands: 3PE.40
Ligand excluded by PLIP3PE.48: 15 residues within 4Å:- Chain U: F.97, P.98, R.99, L.100, I.103, L.155, V.158, L.162
- Chain W: H.10, V.12, A.25, W.60, W.61, H.74, F.89
Ligand excluded by PLIP3PE.49: 13 residues within 4Å:- Chain U: H.154, F.218
- Chain W: Y.184, A.187, T.190, I.191, F.201, G.205, F.206, F.209
- Chain Z: L.93, F.94
- Ligands: 3PE.42
Ligand excluded by PLIP3PE.50: 14 residues within 4Å:- Chain W: M.57, W.61, L.65, T.69, H.74, F.86, F.89, I.213, F.217, R.224, H.229, H.234, V.236, G.237
Ligand excluded by PLIP3PE.51: 9 residues within 4Å:- Chain U: D.230
- Chain W: F.98, W.102, F.105, H.106, A.110, T.112, F.254
- Ligands: 3PE.38
Ligand excluded by PLIP3PE.52: 4 residues within 4Å:- Chain W: R.83, I.87, V.250
- Ligands: 3PE.43
Ligand excluded by PLIP3PE.53: 6 residues within 4Å:- Chain 3: V.79, V.86
- Chain U: L.37
- Chain X: I.29, F.30, G.31
Ligand excluded by PLIP3PE.55: 14 residues within 4Å:- Chain 1: A.30, W.34, H.37, E.41
- Chain U: T.356, F.432, L.435
- Chain V: L.19, G.20, F.21, H.36, H.37, F.40
- Ligands: 3PE.45
Ligand excluded by PLIP3PE.58: 6 residues within 4Å:- Chain 2: Y.50, R.54, Y.57
- Ligands: PC1.36, CDL.39, PC1.56
Ligand excluded by PLIP- 2 x HEC: HEME C(Covalent)
HEC.13: 19 residues within 4Å:- Chain D: V.101, C.102, C.105, H.106, N.170, A.173, Y.174, P.175, P.176, I.181, R.185, Y.191, L.195, L.196, F.218, A.224, M.225, M.228, V.251
19 PLIP interactions:19 interactions with chain D,- Hydrophobic interactions: D:V.101, D:N.170, D:A.173, D:P.175, D:P.176, D:I.181, D:L.195, D:L.196, D:L.196, D:F.218, D:A.224, D:M.225, D:V.251
- Hydrogen bonds: D:Y.191, D:A.224
- Salt bridges: D:R.185
- pi-Stacking: D:H.106, D:H.106
- Metal complexes: D:H.106
HEC.28: 18 residues within 4Å:- Chain N: V.101, C.102, C.105, H.106, N.170, A.173, Y.174, P.175, P.176, I.181, R.185, Y.191, L.195, L.196, F.218, A.224, M.225, M.228
16 PLIP interactions:16 interactions with chain N,- Hydrophobic interactions: N:V.101, N:N.170, N:P.175, N:P.176, N:I.181, N:L.195, N:L.196, N:L.196, N:F.218, N:A.224
- Hydrogen bonds: N:Y.191, N:Y.191
- Salt bridges: N:R.185
- pi-Stacking: N:H.106, N:H.106
- Metal complexes: N:H.106
- 2 x HEA: HEME-A(Non-covalent)
HEA.32: 26 residues within 4Å:- Chain U: W.129, W.239, V.246, Y.247, H.292, H.293, T.311, A.315, G.319, I.322, F.350, G.354, I.358, L.360, A.361, D.366, H.370, V.375, H.378, F.379, V.382, L.383, R.440
- Chain V: I.46, I.89, L.90
27 PLIP interactions:24 interactions with chain U, 3 interactions with chain V,- Hydrophobic interactions: U:W.129, U:W.239, U:V.246, U:V.246, U:A.315, U:I.322, U:F.350, U:I.358, U:A.361, U:F.379, U:F.379, U:V.382, U:L.383, V:I.46, V:I.89, V:L.90
- Hydrogen bonds: U:Y.247, U:Y.247, U:D.366, U:R.440
- Salt bridges: U:H.370, U:R.440
- pi-Stacking: U:H.293
- pi-Cation interactions: U:H.243, U:H.243, U:H.293
- Metal complexes: U:H.378
HEA.33: 30 residues within 4Å:- Chain U: G.24, A.25, G.28, V.29, T.32, S.35, I.38, R.39, Y.57, I.61, H.64, A.65, M.68, I.69, G.128, W.129, Y.373, F.379, H.380, L.383, S.384, L.391, F.392, V.423, F.427, R.440, R.441, S.460, I.467, F.470
25 PLIP interactions:25 interactions with chain U,- Hydrophobic interactions: U:I.61, U:A.65, U:M.68, U:F.379, U:F.379, U:L.383, U:L.391, U:F.392, U:F.392, U:F.427, U:I.467, U:F.470, U:F.470
- Hydrogen bonds: U:W.129, U:S.384, U:R.441
- Salt bridges: U:R.440, U:R.441
- pi-Stacking: U:H.64, U:F.379, U:H.380, U:H.380, U:F.427
- Metal complexes: U:H.64, U:H.380
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x CUA: DINUCLEAR COPPER ION(Covalent)
- 1 x LYS: LYSINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Maldonado, M. et al., Atomic structures of respiratory complex III 2 , complex IV, and supercomplex III 2 -IV from vascular plants. Elife (2021)
- Release Date
- 2021-01-20
- Peptides
- Mitochondrial-processing peptidase subunit beta, mitochondrial isoform X1: AK
Alpha-MPP: BL
COB: CM
cytochrome c1-2, heme protein, mitochondrial: DN
Cytochrome b-c1 complex subunit Rieske, mitochondrial: EO
Cytochrome b-c1 complex subunit 7: FP
cytochrome b-c1 complex subunit 8: GQ
Cytochrome b-c1 complex subunit 6: HR
cytochrome b-c1 complex subunit 9: IS
QCR10: JT
COX1: U
Cytochrome c oxidase subunit 2: V
COX3: W
COX4: X
cytochrome c oxidase subunit 5b-2, mitochondrial: Y
cytochrome c oxidase subunit 6a, mitochondrial: Z
cytochrome c oxidase subunit 6b-1: 0
Cytochrome c oxidase subunit 5C: 1
COX7a: 2
COX7c: 3 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AK
MB
BL
NC
CM
OD
DN
PE
EO
QF
FP
RG
GQ
SH
HR
TI
JS
VJ
KT
WU
aV
bW
cX
dY
eZ
f0
g1
h2
i3
j - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 3 x ZN: ZINC ION(Non-covalent)
- 5 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 9 x CDL: CARDIOLIPIN(Non-covalent)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 29 x 3PE: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
- 2 x HEC: HEME C(Covalent)
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x CUA: DINUCLEAR COPPER ION(Covalent)
- 1 x LYS: LYSINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Maldonado, M. et al., Atomic structures of respiratory complex III 2 , complex IV, and supercomplex III 2 -IV from vascular plants. Elife (2021)
- Release Date
- 2021-01-20
- Peptides
- Mitochondrial-processing peptidase subunit beta, mitochondrial isoform X1: AK
Alpha-MPP: BL
COB: CM
cytochrome c1-2, heme protein, mitochondrial: DN
Cytochrome b-c1 complex subunit Rieske, mitochondrial: EO
Cytochrome b-c1 complex subunit 7: FP
cytochrome b-c1 complex subunit 8: GQ
Cytochrome b-c1 complex subunit 6: HR
cytochrome b-c1 complex subunit 9: IS
QCR10: JT
COX1: U
Cytochrome c oxidase subunit 2: V
COX3: W
COX4: X
cytochrome c oxidase subunit 5b-2, mitochondrial: Y
cytochrome c oxidase subunit 6a, mitochondrial: Z
cytochrome c oxidase subunit 6b-1: 0
Cytochrome c oxidase subunit 5C: 1
COX7a: 2
COX7c: 3 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AK
MB
BL
NC
CM
OD
DN
PE
EO
QF
FP
RG
GQ
SH
HR
TI
JS
VJ
KT
WU
aV
bW
cX
dY
eZ
f0
g1
h2
i3
j - Membrane
-
We predict this structure to be a membrane protein.